local_hospital

Universidade De Santiago De Compostela

Address
Calle Choupana Da S/n, 15706 Santiago de Compostela, Spain

Neoplasms and Blood Cancer Research

At Universidade De Santiago De Compostela, clinical research is focused on neoplasms, with a strong emphasis on hematology and cancers affecting the blood and lymphatic system. The studies are centered on treatment-naïve mantle cell lymphoma, exploring new approaches to improve outcomes for people newly diagnosed with this rare cancer.

  • Evaluating new treatment combinations for mantle cell lymphoma
  • Assessing how effectively therapies can produce deep remission in hematologic malignancies
  • Supporting better disease control for patients with newly diagnosed lymphoma

The research at this educational institution in Santiago De Compostela is aimed at testing whether modern treatment strategies can improve remission rates and strengthen care for patients with lymphoma.

Site Overview

lock Available with ACCESS

Activity Indicator

Last 6 months

lock Available with ACCESS

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 30 therapeutic areas and 15 of 860 IMPs, ranked by number of trials.

lock Available with ACCESS

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 806 compounds, ranked by number of trials.

lock Available with ACCESS

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
277
Sponsors (total)
258
Active sponsors
154

Sponsor Network

Top 154 by active trials.

lock +153 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +89 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 658 other sites in Spain

lock Available with ACCESS

Therapeutic Area Benchmark — Spain

Select a therapeutic area to compare against other sites in Spain.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Spain

Market Share

Country: Spain

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Universidade De Santiago De Compostela

lock Showing 1 of 642 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
(21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancerBayer AG, Bayer Consumer Care AGPhase IIINot RecruitingOct 2023—

IMP list

lock Showing 1 of 860 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Pembrolizumab41Unknown2017-03-072026-10-16

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.